InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Chadha Deepak, Directeur de la Recherche et du Développement. Officer active across 3 companies, notably Brickell Biotech, Inc.. Cumulatively, 3 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €4k. History available since 18 May 2021. The latest transaction was disclosed on 18 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
35,000 sharesCommon StockSEC:0001628280-23-041230:0
2,700 shares@ US$0.819150.0% of flowCommon StockSEC:0001062993-21-004866:0
Ideal exit: 12 Feb 2022 (T+270)
2,700 shares@ US$0.819150.0% of flowCommon StockSEC:0001062993-21-004866
Ideal exit: 12 Feb 2022 (T+270)
3 of 3 declarations
About Chadha Deepak
Deepak Chadha is the Chief Research & Development Officer at Brickell Biotech, Inc. He is responsible for innovation and the development of new products within the company.
